Intervention Protocol

Lamivudine for chronic hepatitis B in adults

  1. Khalid Mumtaz1,*,
  2. Amna Subhan2,
  3. Saeed Hamid3,
  4. Wasim Jafri4

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 18 APR 2007

DOI: 10.1002/14651858.CD006547


How to Cite

Mumtaz K, Subhan A, Hamid S, Jafri W. Lamivudine for chronic hepatitis B in adults (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD006547. DOI: 10.1002/14651858.CD006547.

Author Information

  1. 1

    Aga Khan University Hospital, Department of Medicine, Karachi, Pakistan

  2. 2

    Aga Khan University Hospital, Medicine, Karachi, Sind, Pakistan

  3. 3

    Aga Khan University Hospital, Dept. of Medicine, Karachi, Sind, Pakistan

  4. 4

    The Aga Khan University Hospital, Medicine, Karachi, Sind, Pakistan

*Khalid Mumtaz, Department of Medicine, Aga Khan University Hospital, Stadium Road, P.O. Box 74800, Karachi, Pakistan. khalid.mumtaz@aku.edu. drkmumtaz@yahoo.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 APR 2007

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the beneficial and harmful effects of lamivudine for patients with chronic hepatitis B.